Bioorthogonal chemistry: Bridging chemistry, biology, and medicine.
Journal
Chem
ISSN: 2451-9294
Titre abrégé: Chem
Pays: United States
ID NLM: 101688902
Informations de publication
Date de publication:
10 Aug 2023
10 Aug 2023
Historique:
pmc-release:
10
08
2024
medline:
15
7
2024
pubmed:
15
7
2024
entrez:
15
7
2024
Statut:
ppublish
Résumé
As chemical biologists sought methods to modify and study biomolecules in their native environments, the need for bioorthogonal chemical reactions emerged. These fast and selective reactions between otherwise inert, abiotic functional groups have enabled exploration of some of the most intriguing and challenging questions in chemical biology. Further, the ability to perform organic reactions in cells and organisms has led to important applications in clinical spaces, and one reaction is now an integral part of a phase 2 trial for treating solid tumors. Given that bioorthogonal chemistry was a recipient of the 2022 Nobel Prize, we expect this field to be even more energized. Here, we highlight some of the most recent studies in this sphere and how these set the stage for where bioorthogonal chemistry is headed.
Identifiants
pubmed: 39006002
doi: 10.1016/j.chempr.2023.05.016
pmc: PMC11245302
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2095-2109Déclaration de conflit d'intérêts
DECLARATION OF INTERESTS The authors declare no competing interests.